# Mark Egly Foundation - Annual Goals & OKRs (2026)

**Document Version**: 1.0
**Last Updated**: November 7, 2025
**Planning Period**: Year 1 (November 2025 - October 2026)
**Owner**: Executive Team
**Purpose**: Define specific, measurable objectives and key results for our first full year of operations

---

## ğŸ“‹ Table of Contents

1. [Year 1 Overview](#year-1-overview)
2. [Foundation-Level Objectives](#foundation-level-objectives)
3. [Education OKRs](#education-okrs)
4. [Support OKRs](#support-okrs)
5. [Research OKRs](#research-okrs)
6. [Advocacy OKRs](#advocacy-okrs)
7. [Operations & Fundraising OKRs](#operations--fundraising-okrs)
8. [Quarterly Milestones](#quarterly-milestones)
9. [Team Accountability](#team-accountability)

---

## Year 1 Overview

### What Is Year 1 About?

**Theme**: **FOUNDATION** - Build infrastructure, launch pilots, establish credibility

Year 1 is about:

- âœ… Setting up organizational infrastructure (board, staff, systems)
- âœ… Launching pilot programs to test our theory of change
- âœ… Building credibility with key stakeholders (physicians, patients, funders)
- âœ… Establishing Mark Egly Foundation as a trusted voice for AATD

**What success looks like by October 2026**:

- Strong organizational foundation (board, team, finances)
- All four program areas operational (Education, Support, Research, Advocacy)
- 1,000+ physicians trained
- 500+ patients assisted
- $250K+ in research grants awarded
- Legislation introduced in 3+ states
- $500K raised to fund Year 2 growth

---

### OKR Framework

**What are OKRs?**

- **Objectives**: What we want to achieve (qualitative, inspirational)
- **Key Results**: How we measure success (quantitative, time-bound)

**Our OKR Structure**:

```
OBJECTIVE (What we want to achieve)
â”œâ”€ Key Result 1 (Measurable outcome)
â”œâ”€ Key Result 2 (Measurable outcome)
â””â”€ Key Result 3 (Measurable outcome)
```

**Scoring**:

- 0.0 - 0.3: Red (behind plan)
- 0.4 - 0.6: Yellow (on track but needs attention)
- 0.7 - 1.0: Green (on track or exceeding)

**Note**: OKRs should be ambitious. Achieving 70% is considered success.

---

## Foundation-Level Objectives

### Objective 1: Build a Strong Organizational Foundation

**Why this matters**: We can't achieve our mission without solid infrastructure

**Key Results**:

**KR 1.1**: Form and activate Board of Directors

- **Target**: 5 board members recruited, oriented, and actively engaged
- **Measurement**: Board composition complete + 90%+ attendance at quarterly meetings
- **Owner**: Mark Egly (Founder)

**KR 1.2**: Establish 501(c)(3) compliance infrastructure

- **Target**: All IRS requirements met, accounting systems operational, first audit completed
- **Measurement**: IRS compliance checklist 100% complete + clean audit
- **Owner**: Executive Director

**KR 1.3**: Build core operating systems

- **Target**: CRM (Salesforce), accounting (QuickBooks), website, databases operational
- **Measurement**: All systems live and being used by team
- **Owner**: Operations Manager

**KR 1.4**: Achieve financial sustainability

- **Target**: Raise $500K in Year 1 funding (goal achieved)
- **Measurement**: $500K in committed/received donations
- **Owner**: Development Director

**KR 1.5**: Build core team

- **Target**: 4 full-time staff hired and onboarded by Q2
- **Measurement**: Executive Director, Development Director, Program Manager, Admin Coordinator all in place
- **Owner**: Mark Egly + Executive Director

---

### Objective 2: Establish Mark Egly Foundation as AATD Authority

**Why this matters**: Credibility is essential for fundraising, partnerships, and policy influence

**Key Results**:

**KR 2.1**: Secure national media coverage

- **Target**: 10+ national media placements (print, broadcast, or online)
- **Measurement**: Media tracking report
- **Owner**: Communications Manager (part-time/contractor)

**KR 2.2**: Build strategic partnerships

- **Target**: 10 formal partnerships with medical institutions, patient orgs, or research institutions
- **Measurement**: Signed MOUs or partnership agreements
- **Owner**: Executive Director

**KR 2.3**: Establish medical advisory board

- **Target**: 5 leading AATD experts committed as advisors
- **Measurement**: Advisory board roster published on website
- **Owner**: Mark Egly

**KR 2.4**: Launch professional website

- **Target**: New MarkEglyFoundation.com live by Q2 with full functionality
- **Measurement**: Website launched + 10,000 unique visitors in first 6 months
- **Owner**: Program Manager + contractor

---

## Education OKRs

### Objective 3: Train 1,000 Physicians to Recognize AATD

**Why this matters**: Physician education is the fastest path to reducing diagnostic delays

**Key Results**:

**KR 3.1**: Develop CME-accredited course

- **Target**: "Recognizing AATD in Primary Care" course developed and accredited (5 CEUs)
- **Measurement**: Course approved by AMA PRA + AAFP + available online
- **Owner**: Medical Education Director

**KR 3.2**: Train 1,000 physicians

- **Target**: 1,000 physicians complete CME course by October 2026
- **Measurement**: 1,000 completions in CME platform database
- **Owner**: Medical Education Director

**KR 3.3**: Demonstrate behavior change

- **Target**: 60%+ of trained physicians report testing for AATD more frequently
- **Measurement**: 6-month follow-up survey results
- **Owner**: Medical Education Director

**KR 3.4**: Certify 10 "AATD Aware" institutions

- **Target**: 10 medical institutions (hospitals, clinics, practices) certified
- **Measurement**: 10 institutions meet all certification criteria
- **Owner**: Medical Education Director

---

### Objective 4: Raise Public Awareness of AATD

**Why this matters**: Patients can't ask for testing if they've never heard of AATD

**Key Results**:

**KR 4.1**: Launch patient education hub

- **Target**: Comprehensive patient education section on website (10+ resources)
- **Measurement**: Resources published + 5,000 downloads/views
- **Owner**: Program Manager

**KR 4.2**: Generate 10M media impressions

- **Target**: 10 million total impressions across all channels (earned + paid)
- **Measurement**: Media monitoring report + analytics
- **Owner**: Communications Manager

**KR 4.3**: Build social media presence

- **Target**: 5,000 followers across platforms (Facebook, Twitter/X, Instagram, LinkedIn)
- **Measurement**: Combined follower count
- **Owner**: Communications Manager

**KR 4.4**: Increase public awareness

- **Target**: 8% of US adults have heard of AATD (from 5% baseline)
- **Measurement**: National awareness survey (commissioned Year 1)
- **Owner**: Communications Manager

---

## Support OKRs

### Objective 5: Remove Financial Barriers for 500 Patients

**Why this matters**: Many patients can't afford genetic testing or treatment

**Key Results**:

**KR 5.1**: Launch testing assistance fund

- **Target**: Testing assistance fund operational and processing applications
- **Measurement**: Fund guidelines published + application portal live
- **Owner**: Patient Services Director

**KR 5.2**: Assist 500 patients

- **Target**: 500 patients receive financial assistance for testing or treatment
- **Measurement**: 500 grants disbursed (tracked in CRM)
- **Owner**: Patient Services Director

**KR 5.3**: Achieve high diagnostic yield

- **Target**: 40%+ of testing assistance recipients receive AATD diagnosis
- **Measurement**: Follow-up data from testing labs
- **Owner**: Patient Services Director

**KR 5.4**: Distribute $250K in patient assistance

- **Target**: $250,000 distributed to patients for testing/treatment
- **Measurement**: Financial reports from grants program
- **Owner**: Patient Services Director

---

### Objective 6: Launch Patient Community Platform

**Why this matters**: Patients need community, resources, and support

**Key Results**:

**KR 6.1**: Develop Alpha1Life.com platform

- **Target**: Platform built with core features (forums, resources, events, profiles)
- **Measurement**: Platform live and functional
- **Owner**: Program Manager + contractor

**KR 6.2**: Recruit 1,000 members

- **Target**: 1,000 registered members on Alpha1Life.com by October 2026
- **Measurement**: User registration data
- **Owner**: Community Manager (part-time)

**KR 6.3**: Achieve strong engagement

- **Target**: 30% monthly active user rate (MAU)
- **Measurement**: Analytics showing 300+ MAU
- **Owner**: Community Manager

**KR 6.4**: Establish 25 support groups

- **Target**: 25 support groups launched (virtual or in-person)
- **Measurement**: Support group directory on website
- **Owner**: Patient Services Director

---

### Objective 7: Pilot Patient Navigation Program

**Why this matters**: Newly diagnosed patients need guidance through complex healthcare system

**Key Results**:

**KR 7.1**: Develop navigation program framework

- **Target**: Navigation program design complete (service model, staffing, protocols)
- **Measurement**: Program manual published
- **Owner**: Patient Services Director

**KR 7.2**: Hire and train navigators

- **Target**: 2 patient navigators (RN or social worker) hired and trained
- **Measurement**: 2 FTE navigators on staff
- **Owner**: Patient Services Director

**KR 7.3**: Serve 100 patients

- **Target**: 100 patients receive navigation services (pilot cohort)
- **Measurement**: 100 patients enrolled in CRM
- **Owner**: Patient Navigators

**KR 7.4**: Achieve patient satisfaction

- **Target**: 80+ Net Promoter Score (NPS) from navigation patients
- **Measurement**: Patient satisfaction survey results
- **Owner**: Patient Services Director

---

## Research OKRs

### Objective 8: Launch Research Innovation Pipeline

**Why this matters**: Better testing tools will accelerate diagnosis

**Key Results**:

**KR 8.1**: Complete AAT glucometer feasibility study

- **Target**: Feasibility study published showing technical and market viability
- **Measurement**: Study report completed + reviewed by advisory board
- **Owner**: Research Director

**KR 8.2**: Develop prototype

- **Target**: Working prototype of AAT glucometer completed
- **Measurement**: Prototype demonstrated to advisory board
- **Owner**: Research Director + device partner

**KR 8.3**: Secure device development partner

- **Target**: Partnership agreement signed with medical device company
- **Measurement**: Signed partnership agreement
- **Owner**: Mark Egly + Research Director

**KR 8.4**: File additional patent applications

- **Target**: 2 additional provisional patents filed (building on Mark's existing patent)
- **Measurement**: USPTO filing confirmations
- **Owner**: Mark Egly + patent attorney

---

### Objective 9: Award First Research Grants

**Why this matters**: Funding AATD research accelerates innovation

**Key Results**:

**KR 9.1**: Establish research grant program

- **Target**: Grant program designed (categories, review process, criteria)
- **Measurement**: Grant program guidelines published
- **Owner**: Research Director

**KR 9.2**: Form scientific advisory board

- **Target**: 5 scientific advisors recruited to review grant applications
- **Measurement**: Advisory board roster complete
- **Owner**: Research Director

**KR 9.3**: Award $250K in grants

- **Target**: $250,000 awarded to AATD researchers
- **Measurement**: Grant agreements signed
- **Owner**: Research Director

**KR 9.4**: Launch data donation program

- **Target**: 1,000 patients enrolled in anonymous data donation program
- **Measurement**: 1,000 consents signed + data collected
- **Owner**: Research Director + Data Manager

---

## Advocacy OKRs

### Objective 10: Build Policy Infrastructure for Newborn Screening

**Why this matters**: Policy change creates lasting systemic impact

**Key Results**:

**KR 10.1**: Identify target states

- **Target**: 10 priority states identified with legislative champions
- **Measurement**: State prioritization matrix + champion database
- **Owner**: Advocacy Director

**KR 10.2**: Draft model legislation

- **Target**: Model newborn screening bill drafted and vetted by legal experts
- **Measurement**: Model legislation published on website
- **Owner**: Advocacy Director + legal counsel

**KR 10.3**: Introduce bills in 3 states

- **Target**: Newborn screening legislation introduced in 3 states
- **Measurement**: Bill numbers and legislative tracking
- **Owner**: Advocacy Director

**KR 10.4**: Build grassroots network

- **Target**: 100 trained patient advocates across 10 states
- **Measurement**: Advocate training completion + contact database
- **Owner**: Advocacy Director

---

### Objective 11: Launch Advocacy Coalition

**Why this matters**: We're stronger together with other rare disease orgs

**Key Results**:

**KR 11.1**: Build initial coalition

- **Target**: 10 partner organizations formally join advocacy coalition
- **Measurement**: Coalition partnership agreements signed
- **Owner**: Advocacy Director

**KR 11.2**: Conduct 50 legislative meetings

- **Target**: 50 meetings with legislators across target states
- **Measurement**: Meeting log with outcomes tracked
- **Owner**: Advocacy Director + advocates

**KR 11.3**: Launch petition campaign

- **Target**: 50,000 signatures on newborn screening petition
- **Measurement**: Petition platform data
- **Owner**: Communications Manager + Advocacy Director

**KR 11.4**: Generate policy media coverage

- **Target**: 25 media placements focused on AATD policy
- **Measurement**: Media tracking report (policy-focused)
- **Owner**: Communications Manager

---

## Operations & Fundraising OKRs

### Objective 12: Raise $500K to Fund Operations

**Why this matters**: Without funding, we can't execute programs

**Key Results**:

**KR 12.1**: Secure major gifts

- **Target**: $300K from major donors ($10K+ gifts)
- **Measurement**: Donor database showing committed/received gifts
- **Owner**: Development Director

**KR 12.2**: Win foundation grants

- **Target**: $100K from private foundations
- **Measurement**: Grant awards received
- **Owner**: Development Director

**KR 12.3**: Launch monthly giving program

- **Target**: 200 monthly donors ($25-100/month average)
- **Measurement**: Monthly giving dashboard
- **Owner**: Development Director

**KR 12.4**: Generate patent licensing revenue

- **Target**: $50K from Mark's patent licensing agreements
- **Measurement**: Licensing revenue received
- **Owner**: Mark Egly + business development

**KR 12.5**: Host inaugural fundraising event

- **Target**: Gala or golf tournament raises $50K net
- **Measurement**: Event revenue - expenses
- **Owner**: Development Director + Event Committee

---

### Objective 13: Build Efficient Operations

**Why this matters**: Donors want to see their money go to programs, not overhead

**Key Results**:

**KR 13.1**: Maintain low overhead

- **Target**: 80%+ of budget spent on programs (not overhead/admin)
- **Measurement**: Financial reports showing program expense ratio
- **Owner**: Executive Director + Finance Manager

**KR 13.2**: Build volunteer program

- **Target**: 50 active volunteers contributing 2,000+ hours
- **Measurement**: Volunteer database + hours tracked
- **Owner**: Volunteer Coordinator (part-time)

**KR 13.3**: Achieve clean audit

- **Target**: First annual audit completed with no findings
- **Measurement**: Audit report
- **Owner**: Executive Director + Finance Manager

**KR 13.4**: Establish 3-month operating reserve

- **Target**: $125K in cash reserves (3 months of Year 1 expenses)
- **Measurement**: Bank balance + financial statements
- **Owner**: Executive Director + Development Director

---

## Quarterly Milestones

### Q1: November 2025 - January 2026 (Setup Phase)

**Organizational**:

- âœ… Board of Directors formed (5 members)
- âœ… Executive Director hired
- âœ… Development Director hired
- âœ… Office space secured
- âœ… CRM and accounting systems operational
- âœ… First board meeting held

**Programs**:

- âœ… CME course content outline completed
- âœ… Patient assistance fund guidelines drafted
- âœ… Alpha1Life.com platform design started
- âœ… Research grant program framework designed
- âœ… Model legislation drafted
- âœ… Website redesign project launched

**Fundraising**:

- âœ… Case for support document created
- âœ… Major donor prospect list (50 names)
- âœ… 10 foundation grant applications submitted
- âœ… First 25 donors secured ($50K raised)

**Milestones**:

- ğŸ¯ $100K raised (20% of annual goal)
- ğŸ¯ Core team in place (4 staff)
- ğŸ¯ All program frameworks designed

---

### Q2: February - April 2026 (Launch Phase)

**Organizational**:

- âœ… Program Manager hired
- âœ… Administrative Coordinator hired
- âœ… Medical advisory board formed
- âœ… Scientific advisory board forming
- âœ… Website redesign complete and launched

**Programs**:

- âœ… CME course accredited and launched
- âœ… First 200 physicians trained
- âœ… Patient assistance fund launched
- âœ… First 100 patients assisted
- âœ… Alpha1Life.com beta launch (500 members)
- âœ… First research grants awarded ($50K)
- âœ… Legislation introduced in first state

**Fundraising**:

- âœ… First major gift secured ($50K+)
- âœ… 2 foundation grants awarded
- âœ… Monthly giving program launched (50 donors)
- âœ… Event planning underway (Q4 gala)

**Milestones**:

- ğŸ¯ $250K raised (50% of annual goal)
- ğŸ¯ All programs operational
- ğŸ¯ First media coverage secured

---

### Q3: May - July 2026 (Growth Phase)

**Organizational**:

- âœ… Patient Services Director hired
- âœ… Medical Education Director hired (part-time)
- âœ… 2 Patient Navigators hired
- âœ… First quarterly impact report published

**Programs**:

- âœ… 600 physicians trained (cumulative)
- âœ… 10 institutions certified "AATD Aware"
- âœ… 300 patients assisted (cumulative)
- âœ… Navigation program serving 50 patients
- âœ… Alpha1Life.com: 1,000 members
- âœ… 25 support groups launched
- âœ… AAT glucometer prototype completed
- âœ… Legislation introduced in 2 more states (3 total)

**Fundraising**:

- âœ… Second major gift secured
- âœ… Patent licensing deal signed ($50K revenue)
- âœ… 100 monthly donors
- âœ… Event sponsorships secured

**Milestones**:

- ğŸ¯ $375K raised (75% of annual goal)
- ğŸ¯ 1,000 physicians trained (on track)
- ğŸ¯ AAT glucometer prototype demonstrated

---

### Q4: August - October 2026 (Momentum Phase)

**Organizational**:

- âœ… Research Director hired
- âœ… Advocacy Director hired
- âœ… Annual impact report published (Year 1)
- âœ… Board strategic retreat (Year 2 planning)
- âœ… First annual audit completed

**Programs**:

- âœ… 1,000 physicians trained âœ… (GOAL MET)
- âœ… 500 patients assisted âœ… (GOAL MET)
- âœ… $250K research grants awarded âœ… (GOAL MET)
- âœ… 1,000+ Alpha1Life.com members âœ… (GOAL MET)
- âœ… 100 patients in navigation program âœ… (GOAL MET)
- âœ… 1,000 patients in data donation program âœ… (GOAL MET)
- âœ… 3 states with legislation introduced âœ… (GOAL MET)

**Fundraising**:

- âœ… Inaugural gala held ($50K raised)
- âœ… Year-end giving campaign
- âœ… 200 monthly donors âœ… (GOAL MET)
- âœ… $500K total raised âœ… (GOAL MET)

**Milestones**:

- ğŸ¯ $500K raised âœ… (100% of annual goal)
- ğŸ¯ All Year 1 OKRs achieved or exceeded
- ğŸ¯ Year 2 strategic plan approved

---

## Team Accountability

### Who Owns What?

**Mark Egly (Founder & Board Chair)**:

- Board formation and engagement
- Medical advisory board recruitment
- Patent commercialization
- Major donor cultivation (personal asks)
- Public spokesperson

**Executive Director**:

- Overall strategic execution
- Staff management
- Board support
- Financial management
- Partnership development

**Development Director**:

- Fundraising ($500K goal)
- Donor cultivation and stewardship
- Grant writing
- Fundraising events
- Communications support

**Program Manager**:

- Website and Alpha1Life.com development
- Patient education materials
- Event coordination
- Program coordination across directors
- Volunteer management

**Patient Services Director** (hired Q3):

- Patient assistance fund
- Patient navigation program
- Support group network
- Patient satisfaction

**Medical Education Director** (hired Q3, part-time):

- CME course development
- Physician outreach
- AATD Aware certification
- Medical institution partnerships

**Research Director** (hired Q4):

- Research grant program
- AAT glucometer development
- Data donation program
- Scientific advisory board

**Advocacy Director** (hired Q4):

- Legislative strategy
- Bill introductions
- Coalition building
- Grassroots advocacy

---

### OKR Review Cadence

**Weekly** (Leadership Team):

- Quick check-in on progress
- Identify blockers
- Coordinate across teams

**Monthly** (All Staff):

- OKR scoring (0.0 - 1.0)
- Share wins and challenges
- Adjust tactics if needed

**Quarterly** (Board Meeting):

- Comprehensive OKR review
- Program deep-dives
- Strategic adjustments
- Approve next quarter priorities

**Annual** (Board Strategic Retreat):

- Year 1 results vs. goals
- Learnings and reflections
- Year 2 OKR setting
- Strategic plan updates

---

## Year 1 Success Definition

### We will consider Year 1 successful if we achieve:

**âœ… 70%+ of all Key Results** (OKRs are ambitious by design)

**âœ… All four program areas operational** (Education, Support, Research, Advocacy)

**âœ… Strong organizational foundation** (board, staff, systems, funding)

**âœ… Credibility established** with key stakeholders (physicians, patients, policymakers, funders)

**âœ… Evidence that our theory of change is working** (physicians changing behavior, patients helped, policy traction)

**âœ… Positioned for Year 2 growth** (funding secured, team in place, momentum building)

---

## Celebrating Wins & Learning from Misses

### When We Hit OKRs

**Celebrate**:

- ğŸ‰ Team celebration (acknowledge hard work)
- ğŸ‰ Share with board and donors
- ğŸ‰ Public announcement (build momentum)
- ğŸ‰ Thank partners and volunteers

**Amplify**:

- Document what worked (create playbook)
- Share learnings with team
- Look for opportunities to replicate success

---

### When We Miss OKRs

**Analyze**:

- Was the OKR unrealistic?
- Did we execute poorly?
- Were there external factors?
- What can we learn?

**Adapt**:

- Adjust strategy if needed
- Revise OKR if appropriate
- Communicate transparently
- Recommit to mission

**Example**:

> "We set a goal to train 1,000 physicians but only reached 700. After analysis, we learned that free CME courses have low completion rates. In Year 2, we're adding incentives (malpractice insurance discounts) and shortening the course. We're confident this will help us exceed our Year 2 goal of 6,000 physicians."

---

## Summary: Year 1 Commitments

**By October 2026, the Mark Egly Foundation will**:

âœ… Be a fully operational 501(c)(3) with strong governance
âœ… Have trained 1,000 physicians to recognize AATD
âœ… Have assisted 500 patients financially
âœ… Have launched Alpha1Life.com patient community
âœ… Have awarded $250K in research grants
âœ… Have introduced newborn screening legislation in 3 states
âœ… Have raised $500K to fund Year 2 growth

**Most importantly**: We will have **VALIDATED our theory of change** and proven that the Mark Egly Foundation model works.

**Year 1 is the foundation. Years 2-5 are the transformation.**

---

**Approved by**: Mark Egly Foundation Board of Directors
**Effective Date**: November 1, 2025
**Review Date**: Monthly (OKR scoring), Quarterly (board review)
**Version**: 1.0

---

_"Year 1 is about building the launchpad. Year 2 is when we take off."_

**â€” Mark Egly Foundation Executive Team**

---

## Appendix: OKR Tracking Template

### Monthly OKR Scorecard

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  MARK EGLY FOUNDATION - MONTHLY OKR SCORECARD               â”‚
â”‚  Month: [Month Year]                                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  EDUCATION                                                   â”‚
â”‚  â”œâ”€ Physicians Trained: 234 / 1,000 (0.23) ğŸŸ¡               â”‚
â”‚  â”œâ”€ AATD Aware Institutions: 3 / 10 (0.30) ğŸŸ¡               â”‚
â”‚  â””â”€ Score: 0.27 (ON TRACK)                                  â”‚
â”‚                                                              â”‚
â”‚  SUPPORT                                                     â”‚
â”‚  â”œâ”€ Patients Assisted: 145 / 500 (0.29) ğŸŸ¡                  â”‚
â”‚  â”œâ”€ Alpha1Life Members: 387 / 1,000 (0.39) ğŸŸ¡               â”‚
â”‚  â””â”€ Score: 0.34 (ON TRACK)                                  â”‚
â”‚                                                              â”‚
â”‚  RESEARCH                                                    â”‚
â”‚  â”œâ”€ Grants Awarded: $75K / $250K (0.30) ğŸŸ¡                  â”‚
â”‚  â”œâ”€ Glucometer Prototype: In Progress (0.50) ğŸŸ¢             â”‚
â”‚  â””â”€ Score: 0.40 (ON TRACK)                                  â”‚
â”‚                                                              â”‚
â”‚  ADVOCACY                                                    â”‚
â”‚  â”œâ”€ Bills Introduced: 1 / 3 (0.33) ğŸŸ¡                       â”‚
â”‚  â”œâ”€ Coalition Partners: 6 / 10 (0.60) ğŸŸ¢                    â”‚
â”‚  â””â”€ Score: 0.47 (ON TRACK)                                  â”‚
â”‚                                                              â”‚
â”‚  FUNDRAISING                                                 â”‚
â”‚  â”œâ”€ Total Raised: $178K / $500K (0.36) ğŸŸ¡                   â”‚
â”‚  â”œâ”€ Major Gifts: $120K / $300K (0.40) ğŸŸ¡                    â”‚
â”‚  â””â”€ Score: 0.38 (ON TRACK)                                  â”‚
â”‚                                                              â”‚
â”‚  OVERALL SCORE: 0.37 (ON TRACK FOR YEAR 1)                  â”‚
â”‚                                                              â”‚
â”‚  ğŸŸ¢ 0.7+ (Exceeding)  ğŸŸ¡ 0.4-0.6 (On Track)  ğŸ”´ <0.4 (Risk) â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Notes**:

- Scores of 0.3-0.5 are normal in early months (Year 1 is 12 months)
- Flag anything <0.4 for attention
- Celebrate anything >0.7 (ahead of plan)
- Annual target is 0.7+ for all OKRs (70% = success for ambitious goals)
